Aug. 6 at 7:21 PM
$ESTA
Establishment Labs (NASDAQ: ESTA)
Buy (1)
Price Target:
$117.00
The Stock Is Down, but Our Revenue Estimates Move Up; Reiterate Buy
THE TD COWEN INSIGHT
ESTA shares are down following a largely positive print with key elements of our bull thesis still intact: U.S. and MIS momentum. We view this as a buying opportunity before ESTA benefits further from the steep Preservé training ramp (>300 U.S. surgeons), U.S. new account momentum (now >2,000), and growing utilization, which should drive outperformance and sustained Adj. EBITDA profitability.
